United Guardian (UG) Cost of Revenue (2010 - 2026)
United Guardian's (UG) quarterly Cost of Revenue came in at $1.6 million in Q2 2026, up 16.53% year-over-year from $1.3 million in Q2 2025, and up 7.92% quarter-over-quarter from $1.4 million in Q1 2026.
Analysis
United Guardian (UG) Cost of Revenue (2010 - 2026) Analysis & Trends
United Guardian has disclosed Cost of Revenue across 17 years of filings, most recently posting $1.6 million for Q2 2026.
- In Q2 2026, Cost of Revenue rose 16.53% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $6.0 million (up 17.42% YoY), while the FY2025 annual figure was $5.4 million, down 5.54% from the prior year.
- Cost of Revenue came in at $1.6 million for Q2 2026 at United Guardian, up from $1.4 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $1.7 million in Q3 2023 to a low of $1.1 million in Q3 2022.
- Average Cost of Revenue over 5 years is $1.4 million, with a median of $1.4 million recorded in 2023.
- The largest YoY upside for Cost of Revenue was 62.54% in 2023 against a maximum downside of 36.05% in 2023.
- Over 5 years, Cost of Revenue stood at $1.5 million in 2022, then retreated by 20.37% to $1.2 million in 2023, then fell by 1.03% to $1.2 million in 2024, then surged by 36.32% to $1.6 million in 2025, then decreased by 4.1% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $1.6 million in Q2 2026, $1.4 million in Q1 2026, and $1.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.22 Bn | 626.46 Bn | 17.26 Bn | 8.05 Bn |
| 2 | AbbVie | 440.28 Bn | 433.71 Bn | 12.70 Bn | 4.29 Bn |
| 3 | Merck | 364.30 Bn | 357.16 Bn | 12.21 Bn | 4.40 Bn |
| 4 | Novartis Ag | 268.44 Bn | 260.75 Bn | 11.24 Bn | 3.71 Bn |
| 5 | Pfizer | 158.60 Bn | 146.90 Bn | 10.94 Bn | 4.09 Bn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | 3.51 Bn |
| 7 | Revolution Medicines | 44.31 Bn | 44.31 Bn | - | - |
| 8 | Incyte | 24.98 Bn | 20.45 Bn | 1.57 Bn | 104.96 Mn |
| 9 | United Therapeutics | 21.16 Bn | 18.49 Bn | 683.80 Mn | 99.50 Mn |
| 10 | United Guardian | 32.71 Mn | 23.12 Mn | 1.55 Mn | 1.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Mn |
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.56 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | 1.32 Mn |